Gilead wins FDA approval for Letairis

06/17/2007 | NYTimes.com

Gilead Sciences' Letairis received approval to treat pulmonary arterial hypertension while approval for a similar drug from Encysive Pharmaceuticals was delayed. Encysive says the FDA recommended another clinical trial to prove the efficacy of Thelin, which is approved in Europe and Canada.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX